Millions of Americans continue to encounter significant obstacles in accessing GLP-1 medications, despite recent progress in affordability. As these challenges persist, various patients seek out cheaper, unregulated alternatives.
Stephanie Sy, a PBS News Hour correspondent, delves into this issue in the series titled ‘GLP-1s: Reshaping America.’ With a deep background in journalism, Sy has held anchor and correspondent roles across networks such as ABC News, Al Jazeera America, CBSN, CNN International, and PBS News Hour Weekend. Prior to her current role, she provided comprehensive coverage for Yahoo News during the 2018 Midterm Elections and reported from Donald Trump’s victory party on Election Day 2016.
This investigation also features work from Sam Lane, a reporter and producer within PBS NewsHour’s segment unit, and Mike Fritz, who serves as the deputy senior producer for field segments at PBS NewsHour. These professionals contribute their expertise to uncover the complex landscape surrounding accessibility and affordability of GLP-1s in the United States.